Immunotherapeutic approaches for renal cancer.
Pizza
G
G
Department of Nephrology and Urology, S. OrsolaMalpighi Hospital, Bologna, Italy. gpizza@med.unibo.it
de Vinci
C
C
Viza
D
D
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy / Q000379:methods; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D014165:Transfer Factor / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D019496:Cancer Vaccines; D007376:Interleukin-2; D014165:Transfer Factor